Immunological and Nonimmunological Effects of Indoleamine 2,3-Dioxygenase on Breast Tumor Growth and Spontaneous Metastasis Formation
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2012, 1-12
Abstract
The role of the tryptophan-catabolizing enzyme, indoleamine 2,3-dioxygenase (IDO1), in tumor escape and metastasis formation was analyzed using two pairs ofIdo1+andIdo1−murine breast cancer cell lines.Ido1expression in 4T1 cells was knocked down by shRNA, andIdo1expression in NT-5 cells was upregulated by stable transfection. Growth ofIdo1−tumors and spontaneous metastasis formation were inhibited in immunocompetent mice. A higher level of cytotoxic T lymphocytes was generated by spleen cells from mice bearingIdo1−tumors thanIdo1+tumors. Tumor and metastatic growth was enhanced in immunodeficient mice, confirming an intensified immune response in the absence ofIdo1expression. However,Ido1+tumors grow faster thanIdo1−tumors in immunodeficient SCID/beige mice (lacking T, B, and NK cells) suggesting that someIdo1-controlled nonimmunological mechanisms may be involved in tumor cell growth regulation.In vitroexperiments demonstrated that downregulation ofIdo1in tumor cells was associated with decreased cell proliferation, increased apoptosis, and changed expression of cell cycle regulatory genes, whereas upregulation ofIdo1in the cells had the opposite effects. Taken together, our findings indicate thatIdo1expression could exert immunological and nonimmunological effects in murine breast tumor cells.Keywords
Funding Information
- National Institutes of Health (DK68575)
- Magee Women’s Research Institute and Foundation (DK68575)
This publication has 40 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Receptor desensitization and blockade of the suppressive effects of prostaglandin E2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytesCancer Immunology, Immunotherapy, 2010
- Towards a Genetic Definition of Cancer-Associated InflammationThe American Journal of Pathology, 2010
- Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune PrivilegeInternational Reviews of Immunology, 2010
- Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl PyruvateCancer Research, 2010
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenaseProceedings of the National Academy of Sciences, 2008
- Chemotherapeutic drugs and human tumor cells cytokine networkInternational Journal of Cancer, 2008
- Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseJournal of Clinical Investigation, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- Cancer immunoediting from immune surveillance to immune escapeImmunology, 2007